HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Assessment of antihypertensive efficacy of moexipril in metabolic syndrome].

AuthorsA Ia Ivleva, Iu B Moskvicheva, N V Poluianova, E S Minina, A V Kolesnikova
JournalKardiologiia (Kardiologiia) Vol. 45 Issue 12 Pg. 35-9 ( 2005) ISSN: 0022-9040 [Print] Russia (Federation)
PMID16353045 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Tetrahydroisoquinolines
  • Cholesterol
  • moexipril
Topics
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors (administration & dosage, therapeutic use)
  • Antihypertensive Agents (administration & dosage, therapeutic use)
  • Blood Pressure Determination
  • Body Mass Index
  • Cholesterol (blood)
  • Data Interpretation, Statistical
  • Female
  • Humans
  • Male
  • Metabolic Syndrome (blood, diagnosis, drug therapy)
  • Middle Aged
  • Risk Factors
  • Sphygmomanometers
  • Tetrahydroisoquinolines (administration & dosage, therapeutic use)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: